Hydroxyzine HCL 25 MG tablet 100S

Ended Awarded

Contract number
SPE2D326F374L
Awardee
Awarding agency
Obligated
$2,060

Award facts

Contract value 100% obligated
$2,059.75 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
325411 Medicinal and Botanical Manufacturing
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
New Castle, DE 19720, USA

Award details come from SAM.gov/FPDS.

About this award

Medical Supply Chain, a Defense-designated funding agency, issued a firm-fixed-price delivery order to Marlex Pharmaceuticals Inc. on August 12, 2026, with a ceiling value of $2,059.75. Marlex is a minority-owned, Subcontinent Asian American-owned small disadvantaged business. The order was issued with no set-aside. It procures 100-count hydroxyzine HCl 25 mg tablets for delivery to New Castle, Delaware 19720. Performance runs from award through August 13, 2026.

Quick answers

Who was awarded contract SPE2D326F374L?

SPE2D326F374L was awarded to Marlex Pharmaceuticals Inc. by Medical Supply Chain (Troop Support) on August 12, 2026.

How much is contract SPE2D326F374L worth?

The government has obligated $2,060 on SPE2D326F374L.

Is contract SPE2D326F374L an order under another contract?

Yes. SPE2D326F374L is a delivery order under SPE2D020D0008, an indefinite delivery contract.

Was contract SPE2D326F374L competed?

The extent of competition for SPE2D326F374L was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award